KAINOS Laboratories: Interim report
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Securities report - 49th period (April 1, 2023 - March 31, 2024)
Comsys Holdings, Shimizu Construction, etc. (Part 1)
<1430> Nakamura Toshiaki of First Corporation has a shareholding rate of 23.93% → 24.26%. Reporting obligation start date: May 30, 2024. <1518> Mitsui Matsushima Holdings Co., Ltd. and Sumitomo Mitsui Trust Asset Management Co., Ltd. has a shareholding rate of 5.42% → 4.95%. Reporting obligation start date: May 31, 2024. <1518> Mitsui Matsushima Holdings Co., Ltd. and Nomura Securities Co., Ltd. has a shareholding rate.
KAINOS LABORATORIES: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Kainos Laboratories Sees FY Net Y550.00M
Kainos Laboratories Inc. also released the following forecasts: PARENT 1st Half To Year Ending Sep 2024 Mar 2025 Revenue Y2.65 bln Y5.40 b
Kainos Laboratories FY Parent Net Y637.00M Vs Net Y568.00M
Kainos Laboratories Inc. (4556.TO) Japan Year Ended March 31 PARENT 2024 2023 Revenue Y5.06 bln Y4.92 bln Operating Profit Y865.00 mln Y
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
NISSUI, AXAS HOLDINGS, etc.
<1332>Nissui Nomura Securities Co., Ltd. Stock holding ratio 10.71% → 9.78% reporting obligation date 2024/04/10 <3193>Tori Kizoku Holdings Co., Ltd. Okura Chuji share holding ratio 33.73% → 32.30% reporting obligation occurrence date 2024/04/05 <3260>Espoir J Trust Co., Ltd. Stock holding ratio 8.09% → 6.96% reporting obligation date 2024
Kainos Laboratories Raises FY Dividend Plan to Y32.00
Kainos Laboratories Inc. (4556.TO) PARENT Latest Revision Previous For Year to Mar 2024 Plan Year-end Y32.00 Y25.00 Annual Y32.00
Kainos Laboratories Sees Parent FY Net Y570.00M
Kainos Laboratories Inc. also released the following forecasts: PARENT Year Ending Mar 2024 Revenue Y5.20 bln Operating Profit Y850.00 mln Pretax P
Kainos Laboratories Sees 1H Net Y285.00M
Kainos Laboratories Inc. also released the following forecasts: PARENT 1st Half To Sep 2023 Revenue Y2.60 bln Operating Profit Y425.00 mln Pretax P
Kainos Laboratories Sees FY Net Y570.00M
Kainos Laboratories Inc. also released the following forecasts: PARENT 1st Half To Year Ending Sep 2023 Mar 2024 Revenue Y2.60 bln Y5.
Kainos Laboratories Sees Parent FY Net Y600.00M
Kainos Laboratories Inc. also released the following forecasts: PARENT Year Ending Mar 2023 Revenue Y5.10 bln Operating Profit Y900.00 mln Pr
No Data